May 4 Lumentum Holdings Inc
* Lumentum announces fiscal third quarter 2017 results
* Q3 non-gaap earnings per share $0.49
* Q3 gaap loss per share $0.92
* Q3 revenue $255.8 million versus i/b/e/s view $257.4 million
* Q3 earnings per share view $0.49 -- Thomson Reuters I/B/E/S
* Sees q4 2017 non-gaap earnings per share $0.30 to $0.40
* Sees q4 2017 revenue $220 million to $235 million
* Q4 earnings per share view $0.55, revenue view $273.1 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
UPDATE 1-UK Stocks-Factors to watch on June 29
June 29 Britain's FTSE 100 index is seen opening up 37 points at 7,424 on Thursday, according to financial bookmakers, with futures up 0.52 percent ahead of the cash market open.
AstraZeneca, Chi-Med take kidney cancer drug into final testing
LONDON, June 29 AstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib in a relatively rare type of kidney cancer.